Naamah Bloch

Bar-Ilan University — Israel

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index1.9kcitations23works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gut microbiota and health(4), Mathematical Biology Tumor Growth(4), Clostridium difficile and Clostridium perfringens research(3), Alzheimer's disease research and treatments(2), Computational Drug Discovery Methods(2)

Publications23 total

Ethinylestradiol Transfer into Breast Milk of Women Using Low-Dose Combined Hormonal Contraception Is Negligible
Open Access Journal of Contraception·2025Open Access
Virtual screening of drugs against multiple targets of Alzheimer's disease
Journal of Alzheimer s Disease·2025
Nutrients and Drugs in Alzheimer’s Disease: Harnessing Antioxidants
International journal of Nutrition Pharmacology Neurological Diseases·2025Open Access
Polyoxometalates bind multiple targets involved in Alzheimer’s disease
JBIC Journal of Biological Inorganic Chemistry·2025· 5 citedOpen Access
Autoimmune Disease Classification Based on PubMed Text Mining
Journal of Clinical Medicine·2022· 33 citedOpen Access
Resistance to Antimalarial Monotherapy Is Cyclic
Journal of Clinical Medicine·2022· 6 citedOpen Access
Towards a Consensus on Alzheimer’s Disease Comorbidity?
Journal of Clinical Medicine·2021· 48 citedOpen Access
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Science·2020· 1.5k cited
Arginase Inhibition Supports Survival and Differentiation of Neuronal Precursors in Adult Alzheimer’s Disease Mice
International Journal of Molecular Sciences·2020· 18 citedOpen Access
Arginase Inhibition Supports Survival and Differentiation of Neuronal Precursors in Adult Alzheimer’s Disease Mice
2019· 2 citedOpen Access
Abstract CT042: Fecal microbiota transplantation (FMT) and re-induction of anti-PD-1 therapy in refractory metastatic melanoma patients - preliminary results from a phase I clinical trial (NCT03353402)
Clinical Trials·2019· 3 cited
Abstract CT042: Fecal microbiota transplantation (FMT) and re-induction of anti-PD-1 therapy in refractory metastatic melanoma patients - preliminary results from a phase I clinical trial (NCT03353402)
Cancer Research·2019· 15 cited
Progesterone Increases Bifidobacterium Relative Abundance during Late Pregnancy
Cell Reports·2019· 226 citedOpen Access
The tumor as an organ: comprehensive spatial and temporal modeling of the tumor and its microenvironment
BMC Bioinformatics·2016· 15 citedOpen Access
An Interactive Tool for Animating Biology, and Its Use in Spatial and Temporal Modeling of a Cancerous Tumor and Its Microenvironment
PLoS ONE·2015· 10 citedOpen Access
Developing Oncology Drugs Using Virtual Patients of Vascular Tumor Diseases
2011· 2 cited
Use of Virtual Patient Populations for Rescuing Discontinued Drug Candidates and for Reducing the Number of Patients in Clinical Trials
Alternatives to Laboratory Animals·2009· 12 cited
PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines
Melanoma Research·2002· 72 cited
Gene therapy for malignant melanoma
Melanoma Research·1997
Immune response to vaccination with autologous melanoma transduced to secrete GM-CSF
Melanoma Research·1997
page 1 of 2Next →

Frequent Co-authors

Abraham O. Samson(9), Baruh Polis(5), Karin Ben Zaken(5), Omry Koren(4), Trishna Saha(4), Erez N. Baruch(3), Ilan Youngster(3), Guy Ben‐Betzalel(3), Rona Ortenberg(3), Adi Lahat(3), Lior H. Katz(3), Daniela Dick‐Necula(3), Stephen Raskin(3), Д. Л. Ротин(3), Liat Anafi(3), Camila Avivi(3), Jenny Melnichenko(3), Yael Steinberg‐Silman(3), Ronac Mamtani(3), Hagit Harati(3)